Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/60652
Tipo de documento
Trabalhos apresentados em eventosDireito Autoral
Acesso aberto
Coleções
Metadata
Mostrar registro completo
SOCIODEMOGRAPHIC AND HIV CARE CORRELATES OF SUBSTANCE USE AND SYMPTOMS OF MENTAL DISORDERS AMONG PWH AGED >40 YEARS IN LOW- AND MIDDLEINCOME COUNTRIES IN THE SENTINEL RESEARCH NETWORK OF IEDEA
Título alternativo
Cuidados sociodemográficos e HIV correlatos do uso de substâncias e sintomas de transtornos mentais entre PWH com idade> 40 anos em países de baixa e média renda na Rede de Pesquisa Sentinela da IedeaAutor(es)
Afiliação
Columbia University. New York, USA.
The Ohio State University. Columbus, USA.
University of Bordeaux. National Institute for Health. Bordeaux, France / Medical Research (INSERM). Research Institute for Sustainable Development (IRD). Bordeaux Population Health Research Centre. Bordeaux, France.
Centre for Infectious Disease Research in Zambia. Lusaka, Zambia.
Moi Teaching and Referral Hospital. Eldoret, Kenya.
Instituto Nacional de Ciencias Médicas y Nutrición. Mexico City, Mexico.
Research for Development (RD Rwanda) and Rwanda Military Hospital. Kigali, Rwanda.
TREAT Asia/amfAR – The Foundation for AIDS Research. Bangkok, Thailand.
Centre Médical de Suivi des Donneurs de Sang/ CNTS-CI. Abidjan, Cote D'Ivoire.
University of Cape Town. Centre for Infectious Disease Epidemiology & Research (CIDER). Cape Town, South Africa.
Indiana University School of Medicine. Indianapolis, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Research for Development (RD Rwanda) and Rwanda Military Hospital. Kigali, Rwanda.
Byramjee Jeejeebhoy Government Medical College – Johns Hopkins University Clinical Research Site. Pune, India.
University of North Carolina at Chapel Hill. Chapel Hill, USA.
The Ohio State University. Columbus, USA.
University of Bordeaux. National Institute for Health. Bordeaux, France / Medical Research (INSERM). Research Institute for Sustainable Development (IRD). Bordeaux Population Health Research Centre. Bordeaux, France.
Centre for Infectious Disease Research in Zambia. Lusaka, Zambia.
Moi Teaching and Referral Hospital. Eldoret, Kenya.
Instituto Nacional de Ciencias Médicas y Nutrición. Mexico City, Mexico.
Research for Development (RD Rwanda) and Rwanda Military Hospital. Kigali, Rwanda.
TREAT Asia/amfAR – The Foundation for AIDS Research. Bangkok, Thailand.
Centre Médical de Suivi des Donneurs de Sang/ CNTS-CI. Abidjan, Cote D'Ivoire.
University of Cape Town. Centre for Infectious Disease Epidemiology & Research (CIDER). Cape Town, South Africa.
Indiana University School of Medicine. Indianapolis, USA.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Research for Development (RD Rwanda) and Rwanda Military Hospital. Kigali, Rwanda.
Byramjee Jeejeebhoy Government Medical College – Johns Hopkins University Clinical Research Site. Pune, India.
University of North Carolina at Chapel Hill. Chapel Hill, USA.
Resumo em Inglês
Background: Symptoms of mental disorders and hazardous substance use (HSU) are common among people with HIV (PWH) and associated with poor HIV care outcomes. Research into common mental disorders (CMDs) and HSU among PWH in low- and middle-income countries (LMIC) remains limited. Methods: We analyzed baseline data from the International epidemiology Databases to Evaluate AIDS (IeDEA) Sentinel Research Network cohort of PWH aged >40 years on ART at eight HIV clinics in Brazil, Côte d'Ivoire, India, Kenya, Mexico, Rwanda, Zambia, and Zimbabwe. We estimated the prevalence of hazardous alcohol use (HAU) (AUDIT-C =3 for women, =4 for men) and hazardous drug use (HDU) (ASSIST >3 for cannabis, cocaine, amphetamines, inhalants, sedatives, hallucinogens, or opioids), as well as symptoms of depression (PHQ-9 =10), anxiety (GAD-7 =10), and post-traumatic stress disorder (PTSD) (PCL-5 =33). Log binomial models assessed the association between sociodemographic and HIV care characteristics and HSU and symptoms of CMDs. Results: Of 2,074 participants, the prevalence of HAU and HDU was 20% and 4%, respectively (Table 1). The prevalence of HSU and symptoms of CMDs varied by sex, age, marital status, education, and income, as well as HIV care characteristics (Table 2). The prevalence of depressive symptoms was higher among women than men (PR: 1.5, 95% CI:1.2-1.9) while the prevalence of HAU (PR: 0.5, 95% CI:0.4-0.6) and HDU (PR: 0.50, 95% CI:0.31-0.80) was lower among women than men. Conclusions: Routine screening and treatment for CMDs and HSU among PWH in LMICs are urgently needed, with particular relevance for groups more vulnerable to mental or substance use disorders.
Compartilhar